News

These claims broadly cover URG101 and its use in the treatment of painful bladder syndrome (PBS) by administering a glycosaminoglycan (such as heparin) and a local anesthetic. Urigen

The formal marketing authorization by the European Commission is expected within the next few weeks. Oracea shall be the first drug marketed by MediGene itself. The recommendation for

Based on discussions held during the meeting and prior written communications between Duska and the FDA, the company believes that the FDA would consider a new drug application

Dr Hagey will be responsible for all aspects of pre-clinical and clinical development for Hana’s portfolio of cancer therapeutic and supportive care candidates, reporting to Steven Deitcher, Hana’s

Sartorius Stedim Biotech will offer the pH measurement option in its single-use Fluid Management Technology portfolio designed for the biopharmaceutical industry. The single-use pH sensor offers a wide

Most recently, Mr Fender served as vice president and general manager for Osiris Therapeutics, a stem cell therapeutic company focused on developing and marketing products to treat medical

Under the terms of the agreement, InSite grants exclusive rights to Biem to commercialize AzaSite for ocular bacterial infection in Turkey. An option to distribute to Biem’s export

Under the terms of the agreement, North Park is responsible for worldwide development and commercialization of products containing fluridil for all indications. North Park also acquired an option

The study is a multi-centre, randomized, double-blind and placebo-controlled study planned to include up to 420 patients. The patients are randomized to receive daily doses of either 45mg